Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of an Enzyme-linked Immunosorbent Assay for the Recognition of Procalcitonin Variants and Characterization of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

NCT05703802 is registered in ClinicalTrials.gov with University Hospital Muenster as lead sponsor.

NCT NCT05703802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05703802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of an Enzyme-linked Immunosorbent Assay for the Recognition of Procalcitonin Variants and Characterization of Procalcitonin Variants in Patients With Hyperprocalcitonemia.
Lead sponsor
University Hospital Muenster
Phase
Observational
Overall status
Completed
Start date
February 1, 2022
Completion date
November 1, 2022
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adiposity, granulomatosis with polyangiitis, microscopic polyangiitis, pre-eclampsia, procalcitonin, sepsis, sirs